Cloetta AB (0CL) Q2 2026 Earnings Report

The call conveyed strong operational execution and financial performance: organic volume growth (3.8% YTD) met the company's long-term target, margins were exceptionally high (14.9% in Q2, 13.9% YTD), free cash flow improved and leverage is very low (0.8x). Management also announced concrete geographic expansion progress (Netherlands, U.S., Germany) and a clear CapEx and operating-model roadmap to support future growth. Offsetting these positives are temporary headwinds (Easter phasing), currency translation effects that depressed reported sales, commodity/packaging cost volatility, and planned one-time and marketing investments in H2 that will pressure second-half margins. Overall, the positives (growth, record margins, cash generation, low leverage and tangible expansion steps) outweigh the manageable near-term challenges, while management has been transparent about H2 investments and cost dynamics.

The management reiterated upgraded financial guidance and near-term priorities: long‑term organic growth of 3–4%, a long‑term adjusted EBIT target of 14% (with a mid‑term goal of at least 12% by 2027), and a mid‑term CapEx increase to 4–5% of NSV (step‑up visible from next year), plus a dividend policy targeting a payout above 50% of profit after tax. They noted exceptionally strong H1 metrics (organic growth 3.8% YTD; branded packaged +3.3% in Q2 / 3.4% H1; Pick & Mix ~4.7% YTD), an adjusted operating margin of 14.9% in Q2 and 13.9% YTD (but cautioned that H2 will see higher A&P and one‑off geographic expansion costs so Q2 levels shouldn’t be assumed for H2), Q2 CapEx SEK 40m, Q2 free cash flow SEK 86m (SEK 230m YTD), net debt SEK 1.2bn and net debt/EBITDA 0.8x (well below the <1.5x target), SEK 2.7bn available liquidity, and last year’s dividend paid SEK 401m (SEK 140/share, +27% YoY); execution on supply‑chain, digitalization and commercial investments remains key to achieving these targets.